Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Award
Voting Common Shares, no par value per share
2024-01-02$2.80/sh+30,357$85,000→ 278,602 total
Footnotes (2)
- [F1]These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $85,000.
- [F2]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 129,561 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.